Multi-omics Biomarker Validation
Multi-Omics Biomarker Validation is a translational research methodology that integrates and verifies biological marker candidates across multiple molecular data layers—such as genomics, transcriptomics, proteomics, and metabolomics—to establish their robustness, reproducibility, and clinical relevance in disease detection, prognosis, or therapeutic response prediction.
21
Publications
681
Citations
237
Authors
140
Institutions
Publications per year
2017–2026
17
21
Omics phenotyping in heart failure: the next frontier
Antoni Bayés‐Genís, Peter P. Liu, David E. Lanfear et al. · European Heart Journal · 2020 · 69 citations · Full text
Computational identification of multi-omic correlates of anticancer therapeutic response
Lindsay Stetson, Taylor M. Pearl, Yanwen Chen et al. · BMC Genomics · 2014 · 50 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 21
237
2
h-index
2
h-index
2
h-index
1
h-index
1
h-index
1–5 of 237
140
Seoul National University
Seoul, South Korea
3 h-index
13 publications
584 citations
Harvard University
Cambridge, United States
3 h-index
3 publications
179 citations
Zhongshan Hospital
Shanghai, China
2 h-index
19 publications
269 citations

Sun Yat-sen University
Guangzhou, China
2 h-index
19 publications
269 citations
Case Western Reserve University
Cleveland, United States
2 h-index
3 publications
180 citations
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, China
2 h-index
19 publications
269 citations
Fudan University
Shanghai, China
2 h-index
19 publications
269 citations
Massachusetts Institute of Technology
Cambridge, United States
2 h-index
2 publications
130 citations
1–8 of 140
2 publications · 98 citations
2
h-index
1 publications · 10 citations
1
h-index
IJMS · 1 publications · 70 citations
1
h-index
1 publications · 17 citations
1
h-index
1 publications · 47 citations
1
h-index
1–5